PUNE, India — Distribution of R21/Matrix-MTM️ Malaria Vaccine across the African region marks a significant step in the global fight against malaria. The initial shipment will be sent to the Central African Republic (CAR), followed by other African countries such as South Sudan and Democratic Republic of Congo in the next coming days Out of the total 1,63,800 doses specifically allocated for the CAR region, only 43,200 doses will be dispatched today from Serum Institute of India's facility Serum Institute of India (SII), Novavax, and the University of Oxford celebrate this milestone during an event attended by Hon. Eric Garcetti, US Ambassador to India, in Pune, India, highlighting the successful global partnership between the three countries Till now, Serum Institute of India has manufactured 25 million doses with a capacity to scale up to 100 million doses annually Serum Institute of India, the world’s largest manufacturer of vaccines by number of doses, marks a significant milestone with the shipment of its first set of R21/Matrix-MTM malaria vaccine to Africa.
The initial shipment will be sent to the Central African Republic (CAR), followed by other African countries such as South Sudan and Democratic Republic of Congo in the next coming days. In total, 1,63,800 doses of the R21/Matrix-M malaria vaccine have been specifically allocated for CAR region, out of which only 43,200 doses will be dispatched today from Serum Institute of India’s facility. Developed in col.
